SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Axonics Modulation Technologies, Inc. – IPO: ‘S-1’ on 10/5/18 – ‘EX-10.3’

On:  Friday, 10/5/18, at 5:18pm ET   ·   Accession #:  1193125-18-294804   ·   File #:  333-227732

Previous ‘S-1’:  None   ·   Next:  ‘S-1/A’ on 10/22/18   ·   Latest:  ‘S-1/A’ on 10/25/18   ·   7 References:   

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

10/05/18  Axonics Modulation Techs, Inc.    S-1                   39:6.7M                                   Donnelley … Solutions/FA

Initial Public Offering (IPO):  Registration Statement (General Form)   —   Form S-1
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-1         Registration Statement (General Form)               HTML   1.64M 
 2: EX-3.1      Articles of Incorporation/Organization or By-Laws   HTML     75K 
 3: EX-3.2      Articles of Incorporation/Organization or By-Laws   HTML     17K 
 4: EX-3.3      Articles of Incorporation/Organization or By-Laws   HTML     14K 
 5: EX-3.4      Articles of Incorporation/Organization or By-Laws   HTML     19K 
 6: EX-3.6      Articles of Incorporation/Organization or By-Laws   HTML     65K 
 7: EX-4.1      Instrument Defining the Rights of Security Holders  HTML     29K 
 8: EX-4.2      Instrument Defining the Rights of Security Holders  HTML    134K 
 9: EX-4.3      Instrument Defining the Rights of Security Holders  HTML     52K 
10: EX-4.4      Instrument Defining the Rights of Security Holders  HTML     50K 
11: EX-10.1     Material Contract                                   HTML    158K 
18: EX-10.13    Material Contract                                   HTML    242K 
19: EX-10.14    Material Contract                                   HTML     20K 
20: EX-10.15    Material Contract                                   HTML     18K 
21: EX-10.16    Material Contract                                   HTML    175K 
22: EX-10.17    Material Contract                                   HTML     44K 
23: EX-10.18    Material Contract                                   HTML     44K 
24: EX-10.19    Material Contract                                   HTML     43K 
12: EX-10.2     Material Contract                                   HTML     38K 
25: EX-10.20    Material Contract                                   HTML     43K 
26: EX-10.21    Material Contract                                   HTML     44K 
27: EX-10.22    Material Contract                                   HTML     44K 
28: EX-10.23    Material Contract                                   HTML     44K 
29: EX-10.24    Material Contract                                   HTML     40K 
30: EX-10.25    Material Contract                                   HTML     44K 
31: EX-10.26    Material Contract                                   HTML     28K 
32: EX-10.27    Material Contract                                   HTML     23K 
33: EX-10.28    Material Contract                                   HTML     19K 
34: EX-10.29    Material Contract                                   HTML     17K 
13: EX-10.3     Material Contract                                   HTML     26K 
35: EX-10.30    Material Contract                                   HTML     52K 
14: EX-10.4     Material Contract                                   HTML     12K 
15: EX-10.5     Material Contract                                   HTML     67K 
16: EX-10.6     Material Contract                                   HTML     69K 
17: EX-10.7     Material Contract                                   HTML     59K 
37: EX-21.1     Subsidiaries                                        HTML     12K 
38: EX-23.1     Consent of Experts or Counsel                       HTML     11K 
39: EX-99.1     Miscellaneous Exhibit                               HTML     12K 
36: EX-16.1     Letter re: Change in Certifying Accountant          HTML     11K

EX-10.3   —   Material Contract

This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]

  EX-10.3  

Exhibit 10.3

SECOND AMENDMENT TO LICENSE AGREEMENT

This AMENDMENT TO LICENSE AGREEMENT (“Amendment”) is entered into as of February 25, 2014 (the “Amendment Effective Date”), by and between Alfred E. Mann Foundation for Scientific Research (“AMF”) and Axonics Modulation Technologies, Inc., a Delaware corporation (“Licensee”).

RECITALS

WHEREAS, AMF and License are parties to that certain License Agreement, dated as of October 1, 2013 and that certain Amendment dated February 18, 2014 (together the “License Agreement”), pursuant to which AMF granted Licensee certain rights to develop and commercialize Epione;

WHEREAS, the License Agreement is incorporated herein by reference; and

WHEREAS, as a condition to the Series A Financing, the investors have requested that Licensee and AMF further amend Schedule A of the License Agreement as set forth hereunder.

AGREEMENT

NOW, THEREFORE, in consideration of the mutual covenants contained herein, the parties agree to this Amendment as follows:

1. Defined Terms. The capitalized terms used but not defined herein have the respective meanings ascribed to them in the License Agreement

2. Amendment of Schedule A. Schedule A of the Agreement shall be amended and replaced in its entirety with Schedule A attached as Exhibit A to this Amendment.

3. Continuing Effect. All references to the “Agreement” in the License Agreement shall hereinafter refer to the Agreement as amended by this Amendment. Except as specifically amended by this Amendment, the License Agreement shall remain in full force and effect in accordance with its terms. Sections or other headings contained in this Amendment are for reference purposes only and shall not affect in any way the meaning or interpretation of this Amendment; and no provision of this Amendment shall be interpreted for or against any party because that party or its legal representative drafted the provision.

4. Counterparts. This Amendment may be executed in counterparts, each of which will be considered an original, but all of which together will constitute the same instrument.

[Signature Page Follows]

 

 

Confidential treatment has been requested for portions of this exhibit under 17 C.F.R. Sections §§ 200.80(b)(4) and 230.406. The copy filed herewith omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission.

 

IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed as of the day and year first set forth above.

 

ALFRED E. MANN FOUNDATION FOR SCIENTIFIC RESEARCH
By:   /s/ David Hankin
Name:   David Hankin
Title:   CEO
Date:   February 25, 2014

 

AXONICS MODULATION TECHNOLOGIES, INC.
By:   /s/ Michael Williamson
Name:   Michael Williamson
Title:   SVP/General Counsel
Date:   February 25, 2014

 

 

Confidential treatment has been requested for portions of this exhibit under 17 C.F.R. Sections §§ 200.80(b)(4) and 230.406. The copy filed herewith omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission.

 

2

EXHIBIT A

SCHEDULE A TO THE LICENSE AGREEMENT

 

[***]

   

[***]

   

[***]

   

[***]

[***]

   

[***]

   

[***]

   

[***]

[***]

   

[***]

   

[***]

   

[***]

[***]

   

[***]

   

[***]

   

[***]

[***]

   

[***]

   

[***]

   

[***]

[***]

   

[***]

   

[***]

   

[***]

[***]

   

[***]

   

[***]

   

[***]

[***]

   

[***]

   

[***]

   

[***]

[***]

   

[***]

   

[***]

   

[***]

[***]

   

[***]

   

[***]

   

[***]

[***]

   

[***]

   

[***]

   

[***]

[***]

   

[***]

   

[***]

   

[***]

[***]

   

[***]

   

[***]

   

[***]

[***]

   

[***]

   

[***]

   

[***]

[***]

   

[***]

   

[***]

   

[***]

[***]

   

[***]

   

[***]

   

[***]

[***]

   

[***]

   

[***]

   

[***]

[***]

   

[***]

   

[***]

   

[***]

[***]

   

[***]

   

[***]

   

[***]

[***]

   

[***]

   

[***]

   

[***]

[***]

   

[***]

   

[***]

   

[***]

[***]

   

[***]

   

[***]

   

[***]

[***]

   

[***]

   

[***]

   

[***]

[***]

   

[***]

   

[***]

   

[***]

[***]

   

[***]

   

[***]

   

[***]

[***]

   

[***]

   

[***]

   

[***]

[***]

   

[***]

   

[***]

   

[***]

[***]

   

[***]

   

[***]

   

[***]

[***]

   

[***]

   

[***]

   

[***]

[***]

   

[***]

   

[***]

   

[***]

 

 

Confidential treatment has been requested for portions of this exhibit under 17 C.F.R. Sections §§ 200.80(b)(4) and 230.406. The copy filed herewith omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission.

 

3

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘S-1’ Filing    Date    Other Filings
Filed on:10/5/18None on these Dates
2/25/14
2/18/14
10/1/13
 List all Filings 

7 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/29/24  Axonics, Inc.                     10-K/A     12/31/23   13:1.1M
 2/29/24  Axonics, Inc.                     10-K       12/31/23   88:24M
 5/05/23  Axonics, Inc.                     S-3ASR      5/05/23    5:916K
 3/07/23  Axonics, Inc.                     S-8         3/07/23    4:104K
 3/01/23  Axonics, Inc.                     10-K       12/31/22   82:25M
 3/01/22  Axonics, Inc.                     10-K       12/31/21   79:14M
 3/01/21  Axonics, Inc.                     10-K       12/31/20   80:13M
↑Top
Filing Submission 0001193125-18-294804   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Tue., Apr. 30, 2:50:59.1am ET